Biogenea Pharmaceuticals Ltd.
4 clinical trials · Sponsor
◉ Watch Biogenea Pharmaceuticals Ltd.
| Record | Firm | Date |
|---|---|---|
| COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer (NCT07328087) | Biogenea Pharmaceuticals Ltd. | 2026-02-02 |
| GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer (NCT07316361) | Biogenea Pharmaceuticals Ltd. | 2026-02-02 |
| Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. (NCT07077616) | Biogenea Pharmaceuticals Ltd. | 2025-07-01 |
Track Biogenea Pharmaceuticals Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.